Product Information

XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY is a brand product labeled by OptiNose US, Inc., priced at $40.8802 per ML under NDC 71143037501. Its NADAC has been published 410 times since Oct 17, 2018.

FDA first approved this application on Sep 18, 2017.

The High Outlier badge above means this manufacturer's average price in the fluticasone propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY

fluticasone propionate
$40.8802per ML
High Outlier

Strength

93 ug/1

Manufacturer

OptiNose US, Inc.

NDC

71143037501

Classification

Brand

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

8/19/2026

Active Ingredients

FLUTICASONE PROPIONATE

Approval Type

New Drug (NDA)

FDA Application

NDA209022

FDA Approved

9/18/2017

On Market Since

10/3/2017

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has been published 410 times since Oct 17, 2018, and over the history we have for it it has risen 52.7%. The table below summarizes its recorded NADAC range and movement.

Current price$40.8802 per ML
All-time high$40.9013 (May 13, 2026)
All-time low$26.7752 (Oct 17, 2018)
52-week high$40.9013
52-week low$39.3270
Median price$34.0555
Average price$34.4767
Largest weekly change+5.5% (Jan 13, 2021)
Weeks tracked410
Tracking sinceOct 17, 2018

Price History

1W

+0.0%

1M

+0.0%

3M

+0.0%

6M

-0.1%

1Y

+3.9%

3Y

+14.3%

5Y

+25.0%

All

+52.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone propionate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?

The current National Average Drug Acquisition Cost (NADAC) for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY, manufactured by OptiNose US, Inc., is $40.8802 per ML (NDC 71143037501), effective Aug 19, 2026.

How has the price of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY changed over time?

Over the history we have for it, the NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has risen 52.7%. It has been tracked across 410 weekly CMS publications since Oct 17, 2018.

What are the highest and lowest recorded NADAC prices for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?

Since Oct 17, 2018, the NADAC for XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY has ranged from a low of $26.7752 (Oct 17, 2018) to a high of $40.9013 (May 13, 2026), with a median of $34.0555 per ML.

Are there cheaper alternatives to XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?

No other NADAC-published product currently shares the active ingredient and strength of XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY?

XHANCE 93 MCG EXHALATION DELIVERY NASAL SPRAY (NDC 71143037501) is labeled by OptiNose US, Inc., and CMS classifies it as a brand product.